At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacologic Intervention for Postcessation Weight Gain
In Brief
An observational study for Cardiovascular Diseases and 2 related conditions. Completed.
Detailed Summary
To test pharmacologic intervention for smoking postcessation weight gain using nicotine gum and phenylpropanolamine (PPA).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Obesity
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 1991
Study CompletionJun 1997
First PostedMay 2000
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartJul 1, 1991
Study CompletionJun 1, 1997
TodayJul 2, 2026
Posted 26.1 years ago